Sequel's twiist + Tidepool Loop is the first credible open-source AID platform targeting T2D — sub-scale today but uniquely positioned to ride the 'right to repair' and interoperability narrative.

Market read

Open-source AID + tubed micro-pump + Abbott Libre 3 Plus integration is the most ecosystem-aligned story in the market. The launch ramp depends on payer and clinical validation that Tidepool Loop can deliver.

Competitive Position

Only AID built on Tidepool Loop's open-source algorithm — strong developer + patient-advocacy story.
Tubed micro-pump form factor competitive with Tandem Mobi.
Aggressive payer + health-economics hiring signals US commercial ramp.

Key Threats

Smallest install base (~4K) — clinical and payer adoption is the bottleneck.
Open-source story can be co-opted by larger players adding interop hooks.
Funding runway dependent on launch traction.

Opportunities

Acquisition target for any player wanting an open-stack T2D AID story.
First T2D study for an open-loop algorithm — narrative-defining if it reads out cleanly.
Natural partner for Glooko/Dario/One Drop ecosystem plays.

Talking Points

Only open-source AID system targeting T2D.
Tubed micro-pump form factor without proprietary algorithm lock-in.
Tidepool community provides organic patient-advocacy distribution.

Objection Handlers

"Open-source in a regulated medical device — really?"
Tidepool Loop went through full FDA review. Open-source applies to the algorithm transparency, not the regulatory pathway.